Insider Trading Activity For Acorda Therapeutics Inc (NASDAQ:ACOR)
David Lawrence , Insider of Acorda Therapeutics Inc (NASDAQ:ACOR) reportedly Sold 31,000 shares of the company’s stock at an average price of 27.58 for a total transaction amount of $854,980.00 SEC Form
Insider Trading History For Acorda Therapeutics Inc (NASDAQ:ACOR)
Analyst Ratings History For Acorda Therapeutics Inc (NASDAQ:ACOR)
- On 6/1/2016 Aegis Boost Price Target of rating Buy with a price target of $40.00 to $52.00
- On 1/8/2017 Evercore ISI Set Price Target of rating Hold with a price target of $23.00
- On 10/6/2017 Goldman Sachs Group Reiterated Rating Sell to Sell with a price target of $20.00
- On 11/1/2017 Jefferies Group Boost Price Target of rating Hold with a price target of $22.00 to $25.00
- On 11/9/2017 CIBC Initiated Coverage of rating Market Perform to Market Perform
- On 11/15/2017 Cantor Fitzgerald Lower Price Target of rating Neutral with a price target of $18.00 to $16.00
- On 11/15/2017 Oppenheimer Set Price Target of rating Hold with a price target of $18.00
Recent Trading Activity for Acorda Therapeutics Inc (NASDAQ:ACOR)
Shares of Acorda Therapeutics Inc closed the previous trading session at 27.20 +0.00 0.00% with 3981300 shares trading hands.